ACE-话题@MedSci

#ACE#

496篇内容 | 1571人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1655762, encodeId=05a41655e6272, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ACS Appl Mater Interfaces：李帮经课题组在超分子前药mPEG-β-CD/Fc-CPT的自组装及释放行为研究上获进展, objectType=article, longId=97581, objectId=dc9f9e581d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc9f9e581d8, replyNumber=0, likeNumber=40, createdTime=2017-06-15, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc9f9e581d8, moduleTitle=ACS Appl Mater Interfaces：李帮经课题组在超分子前药mPEG-β-CD/Fc-CPT的自组装及释放行为研究上获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc9f9e581d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655801, encodeId=1b3d165580165, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果, objectType=article, longId=114840, objectId=e1501148404e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1501148404e, replyNumber=0, likeNumber=47, createdTime=2018-01-13, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1501148404e, moduleTitle=NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1501148404e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655784, encodeId=1c9f1655e84f1, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=解析2017年AACE/ACE糖尿病综合管理共识：强化降脂是大势所趋, objectType=article, longId=110792, objectId=54a0110e92cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54a0110e92cf, replyNumber=0, likeNumber=58, createdTime=2018-01-17, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54a0110e92cf, moduleTitle=解析2017年AACE/ACE糖尿病综合管理共识：强化降脂是大势所趋, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54a0110e92cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655773, encodeId=e9641655e7342, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=JAHA：China PEACE研究对比中美心梗医疗质量：中国得80分，美国99.4分, objectType=article, longId=104656, objectId=bbc110465657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbc110465657, replyNumber=0, likeNumber=59, createdTime=2017-08-07, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbc110465657, moduleTitle=JAHA：China PEACE研究对比中美心梗医疗质量：中国得80分，美国99.4分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbc110465657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655770, encodeId=20101655e70bb, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=“坏”胆固醇的克星：新药Anacetrapib将问世！, objectType=article, longId=103707, objectId=20cc103e0708, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20cc103e0708, replyNumber=0, likeNumber=54, createdTime=2017-10-09, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20cc103e0708, moduleTitle=“坏”胆固醇的克星：新药Anacetrapib将问世！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20cc103e0708)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655752, encodeId=851f1655e52c8, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=FDA授予礼来/阿斯利康阿尔茨海默氏症药物口服BACE抑制剂AZD3293快车道地位, objectType=article, longId=75773, objectId=b12ae57730c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12ae57730c, replyNumber=0, likeNumber=67, createdTime=2017-04-13, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12ae57730c, moduleTitle=FDA授予礼来/阿斯利康阿尔茨海默氏症药物口服BACE抑制剂AZD3293快车道地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12ae57730c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655772, encodeId=6ef31655e72fa, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ACS Applied Materials & Interfaces：微型机器人或可清除水中致病细菌, objectType=article, longId=104086, objectId=75921040860b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75921040860b, replyNumber=0, likeNumber=47, createdTime=2018-04-10, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75921040860b, moduleTitle=ACS Applied Materials & Interfaces：微型机器人或可清除水中致病细菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75921040860b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655753, encodeId=da961655e53bd, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Am J Clin Nutr：接受ACEI或ARB治疗的肾功正常患者要不要限钾？, objectType=article, longId=77610, objectId=23e3e761018, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23e3e761018, replyNumber=0, likeNumber=46, createdTime=2017-08-22, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23e3e761018, moduleTitle=Am J Clin Nutr：接受ACEI或ARB治疗的肾功正常患者要不要限钾？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23e3e761018)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655763, encodeId=d3bc1655e63b9, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ACS Appl Mater Interfaces：汪世龙课题组等一种新型多功能树枝状介孔硅纳米颗粒搭载姜黄素治疗乳腺癌的研究, objectType=article, longId=97613, objectId=d5cd9e613a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5cd9e613a6, replyNumber=0, likeNumber=71, createdTime=2018-03-18, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5cd9e613a6, moduleTitle=ACS Appl Mater Interfaces：汪世龙课题组等一种新型多功能树枝状介孔硅纳米颗粒搭载姜黄素治疗乳腺癌的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5cd9e613a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655760, encodeId=c51d1655e6047, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Heart：高心血管风险的患者是选择ACEIs还是ARBs？, objectType=article, longId=91658, objectId=06e191658b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06e191658b6, replyNumber=0, likeNumber=55, createdTime=2018-02-12, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06e191658b6, moduleTitle=Heart：高心血管风险的患者是选择ACEIs还是ARBs？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06e191658b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655754, encodeId=72061655e544b, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=2016AACE/ACE临床指南——绝经后骨质疏松症的诊断和治疗发布, objectType=article, longId=78145, objectId=697ce814569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=697ce814569, replyNumber=0, likeNumber=15, createdTime=2017-03-04, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=697ce814569, moduleTitle=2016AACE/ACE临床指南——绝经后骨质疏松症的诊断和治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=697ce814569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655743, encodeId=ac9c1655e43ce, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=AACE 2016：神经内分泌肿瘤与B淋巴细胞刺激因子水平研究, objectType=article, longId=69444, objectId=f3a56944487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3a56944487, replyNumber=0, likeNumber=60, createdTime=2017-02-11, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3a56944487, moduleTitle=AACE 2016：神经内分泌肿瘤与B淋巴细胞刺激因子水平研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3a56944487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655746, encodeId=f02c1655e466a, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=AACE 2016：利拉鲁肽+胰岛素治疗1型糖尿病疗效喜人, objectType=article, longId=69610, objectId=49ce6961069, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49ce6961069, replyNumber=0, likeNumber=78, createdTime=2016-11-17, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49ce6961069, moduleTitle=AACE 2016：利拉鲁肽+胰岛素治疗1型糖尿病疗效喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49ce6961069)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655749, encodeId=54cb1655e49c4, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=WCIO：地塞米松和福沙吡坦可以降低DEB TACE术后PES风险, objectType=article, longId=70935, objectId=dd36e09355e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd36e09355e, replyNumber=0, likeNumber=59, createdTime=2016-12-05, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd36e09355e, moduleTitle=WCIO：地塞米松和福沙吡坦可以降低DEB TACE术后PES风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd36e09355e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655748, encodeId=1f641655e48b8, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=AACE/ACE联合怒推《肥胖患者综合治疗临床实践指南》, objectType=article, longId=69885, objectId=6dd76988596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dd76988596, replyNumber=0, likeNumber=56, createdTime=2017-01-06, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dd76988596, moduleTitle=AACE/ACE联合怒推《肥胖患者综合治疗临床实践指南》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dd76988596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655755, encodeId=f3aa1655e5597, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=2016注射用洛铂在原发性肝癌TACE治疗中的专家共识发布, objectType=article, longId=79100, objectId=72a1e9100af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72a1e9100af, replyNumber=0, likeNumber=17, createdTime=2016-11-13, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72a1e9100af, moduleTitle=2016注射用洛铂在原发性肝癌TACE治疗中的专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72a1e9100af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655756, encodeId=c9bd1655e565d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=6亿美金砸向生命领域，扎克伯格的细胞FaceBook将怎样改变世界？, objectType=article, longId=81843, objectId=c2938184370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2938184370, replyNumber=0, likeNumber=67, createdTime=2017-01-10, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2938184370, moduleTitle=6亿美金砸向生命领域，扎克伯格的细胞FaceBook将怎样改变世界？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2938184370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655741, encodeId=93881655e416c, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=AACE 2016：补充维生素D有望缓解糖尿病视网膜病变, objectType=article, longId=69442, objectId=ce8f69442a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce8f69442a0, replyNumber=0, likeNumber=67, createdTime=2017-02-17, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce8f69442a0, moduleTitle=AACE 2016：补充维生素D有望缓解糖尿病视网膜病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce8f69442a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655744, encodeId=7b2d1655e4450, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=AACE 2016：糖尿病患者长途旅行时，怎么办？, objectType=article, longId=69459, objectId=e06f69459f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e06f69459f1, replyNumber=0, likeNumber=76, createdTime=2017-02-21, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e06f69459f1, moduleTitle=AACE 2016：糖尿病患者长途旅行时，怎么办？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e06f69459f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655745, encodeId=ee131655e4573, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=AACE 2016：使用PET/CT诊断高危肾上腺恶性肿瘤时应谨慎, objectType=article, longId=69516, objectId=0f8b6951667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f8b6951667, replyNumber=0, likeNumber=63, createdTime=2017-03-28, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f8b6951667, moduleTitle=AACE 2016：使用PET/CT诊断高危肾上腺恶性肿瘤时应谨慎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f8b6951667)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACE

2020-05-29

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ACS Appl Mater Interfaces：李帮经课题组在超分子前药mPEG-β-CD/Fc-CPT的自组装及释放行为研究上获进展

2017-06-15

shanyongle (审核中...)

前往app查看评论内容

#ACE#

NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果

2018-01-13

shanyongle (审核中...)

前往app查看评论内容

#ACE#

解析2017年AACE/ACE糖尿病综合管理共识：强化降脂是大势所趋

2018-01-17

shanyongle (审核中...)

前往app查看评论内容

#ACE#

JAHA：China PEACE研究对比中美心梗医疗质量：中国得80分，美国99.4分

2017-08-07

shanyongle (审核中...)

前往app查看评论内容

#ACE#

“坏”胆固醇的克星：新药Anacetrapib将问世！

2017-10-09

shanyongle (审核中...)

前往app查看评论内容

#ACE#

FDA授予礼来/阿斯利康阿尔茨海默氏症药物口服BACE抑制剂AZD3293快车道地位

2017-04-13

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ACS Applied Materials & Interfaces：微型机器人或可清除水中致病细菌

2018-04-10

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Am J Clin Nutr：接受ACEI或ARB治疗的肾功正常患者要不要限钾？

2017-08-22

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ACS Appl Mater Interfaces：汪世龙课题组等一种新型多功能树枝状介孔硅纳米颗粒搭载姜黄素治疗乳腺癌的研究

2018-03-18

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Heart：高心血管风险的患者是选择ACEIs还是ARBs？

2018-02-12

shanyongle (审核中...)

前往app查看评论内容

#ACE#

2016AACE/ACE临床指南——绝经后骨质疏松症的诊断和治疗发布

2017-03-04

shanyongle (审核中...)

前往app查看评论内容

#ACE#

AACE 2016：神经内分泌肿瘤与B淋巴细胞刺激因子水平研究

2017-02-11

shanyongle (审核中...)

前往app查看评论内容

#ACE#

AACE 2016：利拉鲁肽+胰岛素治疗1型糖尿病疗效喜人

2016-11-17

shanyongle (审核中...)

前往app查看评论内容

#ACE#

WCIO：地塞米松和福沙吡坦可以降低DEB TACE术后PES风险

2016-12-05

shanyongle (审核中...)

前往app查看评论内容

#ACE#

AACE/ACE联合怒推《肥胖患者综合治疗临床实践指南》

2017-01-06

shanyongle (审核中...)

前往app查看评论内容

#ACE#

2016注射用洛铂在原发性肝癌TACE治疗中的专家共识发布

2016-11-13

shanyongle (审核中...)

前往app查看评论内容

#ACE#

6亿美金砸向生命领域，扎克伯格的细胞FaceBook将怎样改变世界？

2017-01-10

shanyongle (审核中...)

前往app查看评论内容

#ACE#

AACE 2016：补充维生素D有望缓解糖尿病视网膜病变

2017-02-17

shanyongle (审核中...)

前往app查看评论内容

#ACE#

AACE 2016：糖尿病患者长途旅行时，怎么办？

2017-02-21

shanyongle (审核中...)

前往app查看评论内容

#ACE#

AACE 2016：使用PET/CT诊断高危肾上腺恶性肿瘤时应谨慎

2017-03-28

科室
- - 订阅+
  - 更多科室
工具
服务